title: Endovascular occlusion of a ruptured transitional aneurysm associated with a developmental venous anomaly. Case report.
abstract: Developmental venous anomalies (DVAs) represent a rare cause of intraparenchymal hemorrhage. This case demonstrates an unusual DVA associated with venous hypertension, arteriovenous shunting, and a ruptured transitional aneurysm. The authors describe the first use of embolization as a treatment method for an unstable ruptured transitional aneurysm associated with a DVA. This 33-year-old man suffered acute onset of headache, gait ataxia, and left hemiparesis. Computed tomography brain scans demonstrated a deep paramedian right frontal intraparenchymal hemorrhage. No cavernous malformation was apparent on MR imaging. Diagnostic angiography revealed arteriovenous shunting from the right anterior and middle cerebral arteries to a large DVA with an associated arteriovenous fistula, with a 3-mm aneurysm in the transition from pericallosal artery to the collecting vein. Both surgical and endovascular treatment options were considered. The patient underwent repeat angiography on hospital Day 7, at which time the aneurysm had increased to 5 mm, and endovascular treatment was selected. Acrylic occlusion of the aneurysm was performed and confirmed angiographically. The patient's neurological symptoms resolved throughout the hospital stay, and he remains symptom free in the 10 months since treatment. Developmental venous anomalies are not usually associated with arteriovenous shunting and aneurysms as a source of intraparenchymal hemorrhage. Endovascular occlusion of the aneurysm without blockage of physiologically necessary venous structures is a possible method of treatment for this complex mixed vascular lesion, and has proven safe and effective in this patient. To the authors' knowledge, this is the first presentation of this situation in the literature.
authors.affiliation: Department of Neurological Surgery, Columbia University Medical Center, New York, New York 10032, USA. afd12@columbia.edu
authors.forename: Andrew F
authors.initials: AF
authors.lastname: Ducruet
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Kellner
authors.forename: E Sander
authors.initials: ES
authors.lastname: Connolly
authors.forename: Philip M
authors.initials: PM
authors.lastname: Meyers
mesh_terms: D000328:Adult; D001164:Arteriovenous Fistula / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D020785:Central Nervous System Vascular Malformations / Q000150:complications* / Q000175:diagnosis / Q000601:surgery*; D002533:Cerebral Angiography; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D002550:Cerebral Veins / Q000002:abnormalities / Q000503:physiopathology / Q000601:surgery*; D003487:Cyanoacrylates / Q000627:therapeutic use; D004621:Embolization, Therapeutic / Q000379:methods*; D005625:Frontal Lobe / Q000098:blood supply / Q000473:pathology / Q000601:surgery; D006261:Headache / Q000209:etiology; D006801:Humans; D002532:Intracranial Aneurysm / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery*; D008297:Male; D008845:Microinjections / Q000295:instrumentation / Q000379:methods; D010291:Paresis / Q000209:etiology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D003487:Cyanoacrylates